GPR55 and neoplasm: GPR55 is a G-protein-coupled receptor (GPCR) [21] whose activation by anandamide, 2-arachidonoylglycerol (2-AG) or lysophosphatidylinositol (LPI) as the main ligands resulted in higher tumor cell aggressiveness [22–24].